CareTrust REIT Q2 net income slightly beats, raises 2026 outlook
CTRE•Analyst view
The current average analyst rating on the shares is buy, with 11 strong buy or buy ratings, 1 hold, and no sell or strong sell ratings.
The average consensus recommendation for the specialized REITs peer group is buy.
Wall Street's median 12-month price target for CareTrust REIT, Inc. is $45.50, about 10.6% above its August 5 closing price of $41.14.
The stock recently traded at 27 times next 12-month earnings, versus 26 times three months ago.
Raised 2026 outlook
The company raised its 2026 guidance and now expects:
- Net income of $1.53-$1.56 per share
- Normalized FFO of $2.03-$2.06 per share
- Normalized FAD of
